Author:
Kim Ki Yeon,Yoon Minsang,Cho Youngkyung,Lee Kwang-Hoon,Park Sora,Lee Se-ra,Choi So-Young,Lee Deokjae,Yang Chansik,Cho Eun Hye,Jeon Sangjun Davie,Kim Seok-Hyung,Kim Chungho,Kim Moon Gyo
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Kim MG, Chen C, Lyu MS, Cho EG, Park D, Kozak C, et al. Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics Springer-Verlag. 1999;49:420–8.
2. Lin CY, Anders J, Johnson M, Sang QA, Dickson RB. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem. 1999;274:18231–6.
3. Takeuchi T, Shuman MA, Craik CS. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane- type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci. 1999;96:11054–61.
4. Hooper JD, Clements JA, Quigley JP, Antalis TM. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. American Society for Biochemistry and Molecular Biology. 2001;276:857–60.
5. Lee MS. Matrix-Degrading Type II Transmembrane Serine Protease Matriptase: Its Role in Cancer Development and Malignancy. J Cancer Molecules. 2006:183–90.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献